Humanaut Health

CV Risk Assessment Tool

Cardiovascular Risk Stratification & Referral Routing
Clinical Decision Support — Does Not Replace Clinical Judgment
About This Tool
Who it's for: Nurse practitioners and physicians.
What it's based on: The 2018 ACC/AHA Cholesterol Guideline (risk enhancers), ATP III criteria (metabolic syndrome), and the AHA PREVENT equations as recommended by the 2026 Dyslipidemia Guideline for formal risk estimation.
How to use it: Enter the patient's data to generate a cardiovascular risk assessment and a referral-routing recommendation — NP-level management, physician or PCP, or cardiology — with the appropriate urgency. For increased-risk, non-urgent patients, the tool also flags when the Path provider should order a CAC or Cleerly CCTA directly (no physician visit required first), with a brief contraindication screen.
Developed by Amy Killen, MD · July 2026 · Rev. Aug 2026 (NP-ordered CCTA/Cleerly pathway)
1 Patient Information
2 Standard Risk Factors
3 Lab Values
<100 / 100-159 / ≥160
<40M/50F / 40-59 / ≥60
<150 / 150-199 / ≥200
<90 / 90-129 / ≥130
<30 / 30-49 / ≥50
<1.0 / 1.0-1.9 / ≥2.0
<8 / 8-12 / >12
<5.7 / 5.7-6.4 / ≥6.5
<10 / 10-15 / ≥15
<6 / 6-7 / >7
<100 / 100-125 / ≥126
≥60 / 30-59 / <30
4 Imaging & Fitness
A Risk Enhancers
B Estimated ASCVD Risk Category
Formal risk should be calculated with the AHA PREVENT equations (10- and 30-year total CVD, ages 30–79) at professional.heart.org/en/guidelines-and-statements/prevent-calculator — the standard recommended by the 2026 Dyslipidemia Guideline, replacing the older Pooled Cohort Equations. This tool provides a category estimate based on risk-factor burden, not a formal percent.
C Decision & Routing
D Specific Recommendations
E Scope & Referral Summary